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Background: Accumulating evidence demonstrates minimal benefit and increased risk of off-
label use of atypical antipsychotic medications for dementia-related behaviors.  Optimal strategy 
for disseminating evidence-based guides to nursing home (NH) stakeholders is unclear. Our 
objective is to describe the impact of differing dissemination efforts in Connecticut NHs.  
Methods:  Forty-three Connecticut NHs were randomized to one of 3 arms receiving 
incrementally intensive dissemination strategies of the Agency for Healthcare Research and 
Quality Comparative Effectiveness Review Summary Guide on the off-label use of atypical 
antipsychotic drugs, which was included in a toolkit informed by a needs assessment of NHs. All 
NHs received the paper-based toolkit and notifications regarding the online toolkit. Additionally, 
Arm 2 received individualized quarterly audit and feedback reports with atypical antipsychotic 
prescribing rates; Arm 3 received in-person educational visits and audit and feedback reports. 
Toolkit reach was assessed using interviews with NH leadership and staff. Online toolkit use 
was assessed using Google analytics.  
Results:  Eighty leaders and 222 direct care staff were interviewed. Leadership and direct care 
staff in Arm 3 NHs were more likely to be familiar with the toolkit that those in Arm 1 (p=0.008) 
and Arm 2 (p<0.0001). Several leaders and direct care staff identified the patient-centered 
behavior management section of the toolkit as the most useful. Google analytics showed no 
difference in the use of the online toolkit among NHs (p=0.30).  
Conclusions: Intensive dissemination, using multi-pronged approach including academic 
detailing and direct care staff trainings, appeared to be associated with higher familiarity with 
paper-based toolkit, but not Internet-based use of the toolkit in the NH setting.   
  
 
